Bridging the Gap in MedTech Innovation

We translate promising UK university research into real-world solutions by funding development, fostering collaboration in Yorkshire, and powering the next generation of MedTech spinouts.

Programme Overview

We offer three levels of funding—from £15k for market validation through to £120k for Proof of Concept—alongside funding secondment opportunities for knowledge exchange plus training and events.

The Yorkshire MedTech Impact Accelerator

Supporting academics across regional and national universities to bridge the gap between primary research and clinical implementation. Supported by EPSRC and led jointly by the Universities of Leeds and Sheffield, we strengthen the region’s thriving MedTech ecosystem by providing the crucial translational link—advancing innovations to drive measurable impact for patients and healthcare systems.

Latest Impact

Yorkshire Firms Take Centre Stage as Medilink Marks 30 Years of Healthcare Innovation

Innovation across borders: Yorkshire MedTech champions regional strengths on China mission

Medical technology innovation in Yorkshire: translational funding opportunities

Insigneo Institute & Yorkshire MedTech Industry Day: Shaping the Future of Health Technologies.

Round 6 Impact Project Funding coming soon!

Round 5 has now closed and applications are in review - but it's not too early to start preparing for the next call

Why Choose Yorkshire MedTech Funding?

Staged progression

Funding pathway that grows with your project from market validation through to proof of concept

Speed and efficiency

At least 2 funding calls per year, decisions within 8 weeks and funding released within 4 months subject to contract

Support and guidance

Expert panel feedback to strengthen your commercialisation strategy

Innovation and quality

Part of the prestigious national EPSRC ‘PBIAA’ network of 17 regional innovation hubs totalling £81m investment

Growth and progress

Follow-on funding encouraged as projects mature, supporting your journey from research to market